Danielle Bucco

Articles

Precision Medicine a Necessary Component in HER2+ Breast Cancer Care

December 18th 2017

Mothaffar Fahed Rimawi, MD, discusses the significance of precision medicine in HER2-positive breast cancer, as well as the possible role of immunotherapy for this specific population.

Immunotherapy Emerges in Stage III NSCLC Treatment Landscape

December 17th 2017

John Heinzerling, MD, discusses the impact of durvalumab and other developments in the treatment of patients with stage III non-small cell lung cancer.

Deeper Understanding Emerging of KRAS Biology in NSCLC

December 16th 2017

Ferdinandos Skoulidis, MD, PhD, discusses potential treatment options for KRAS-mutated lung cancer and highlighted developments in biomarker research in other areas in the field.

Combinations Have Potential to Shift CLL Treatment Paradigm

December 13th 2017

Richard Furman, MD, discusses the current management of chronic lymphocytic leukemia and the future of combinations, including venetoclax and ibrutinib, for this patient population.

Combination Therapies Push Melanoma Field Forward

December 12th 2017

Michael A. Postow, MD, discusses the evolution of combination therapies for patients with melanoma.

Immunotherapy Combinations Poised to Shift Standard of Care in RCC

December 7th 2017

Hans Hammers, MD, PhD, discusses the game-changing combination of nivolumab and ipilimumab and highlighted other combinations that have potential in the treatment of patients with renal cell carcinoma.

Expert Discusses Developments in ALK/ROS1-Positive NSCLC

December 6th 2017

Vincent K. Lam, MD, discusses the treatment paradigm for patients with ALK/ROS1-translocated NSCLC.

Oncologist Discusses Medical Marijuana for Chronic Pain Management

December 5th 2017

Jerry W. Mitchell, MD, discusses the use of medical marijuana as a chronic pain relief for patients with hematologic malignancies ad other tumor types.

Simon Says Immunotherapy Combo Regimens on Horizon in NSCLC

December 4th 2017

George R. Simon, MD, discusses the advancements being made with immunotherapy for the treatment of NSCLC.

Optimal Sequencing and Patient Selection Investigated in NSCLC

December 4th 2017

Frank E. Mott, MD, discusses optimal treatment selection strategies for patients with NSCLC.

Role of Neoadjuvant Chemotherapy Evolving in TNBC

December 4th 2017

Melanie Majure, MD, discusses the optimal role chemotherapy for patients with TNBC and the importance of achieving a pCR.

Immunotherapy Combo Regimens Next Step in Bladder Cancer

November 30th 2017

Elizabeth Plimack, MD, discusses the impact of the immunotherapy approvals in the first- and second-line setting for bladder cancer and the future of combinations for these patients.

Future of Bladder Cancer Care to Include Immunotherapy Combos

November 29th 2017

Petros Grivas, MD, shares insight on the value of combining immunotherapy regimens in the treatment of patients with urothelial carcinoma.

Treatment Strategies Expanding for Elderly Patients With CLL

November 27th 2017

Jacqueline Claudia Barrientos, MD, discusses the appropriate treatment strategies for elderly patients with chronic lymphocytic leukemia.

Alternative Treatment Options Emerging for Relapsed Pediatric Patients With ALL

November 27th 2017

Susan R. Rheingold, MD, discusses the impact of CAR T-cell therapy on patients with ALL and options for patients who relapse on treatment.

Expert Highlights Expanding Options for HER2+ Breast Cancer

November 27th 2017

Lajos Pusztai, MD, discusses neoadjuvant and adjuvant treatment decisions for patients with HER2-positive breast cancer, as well as the potential of immunotherapy in the metastatic setting.

Role of Immunotherapy Being Defined in Colorectal Cancer

November 23rd 2017

A. David McCollum, MD, discusses the optimal management of CRC in the first-line setting and the ongoing research with checkpoint inhibitors designed to benefit larger groups of patients.

Novel Treatments Emerging in Pancreatic Cancer

November 22nd 2017

Carlos Becerra, MD, discusses the current management and emerging therapies for patients with pancreatic cancer.

Immunotherapy to Have Emerging Role in Squamous Cell Lung Cancer

November 22nd 2017

George R. Blumenschein, MD, discusses the current treatment landscape for patients with squamous cell lung cancer.

Expert Shares Insight on Role of RT, Surgery in Prostate Cancer

November 21st 2017

Jonathan Warner, MD, discusses the evolving role of surgery and radiation therapy in the treatment landscape for patients with prostate cancer.